HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

5- ((5- fluoro- 2- oxo- 1,2- dihydro- 3H- indol- 3- ylidene)methyl)- N- (2- hydroxy- 3- morpholin- 4- ylpropyl)- 2,4- dimethyl- 1H- pyrrole- 3- carboxamide

has both antineoplastic and antiangiogenic activities; structure in first source
Also Known As:
SU 14813; SU-14813; SU14813
Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Hu-Lowe, Dana: 2 articles (11/2011 - 07/2006)
2. Patyna, Shem: 2 articles (11/2011 - 07/2006)
3. Brega, Nicoletta: 1 article (11/2011)
4. Abbattista, A: 1 article (01/2011)
5. Bokemeyer, C: 1 article (01/2011)
6. Boven, E: 1 article (01/2011)
7. Brega, N: 1 article (01/2011)
8. Courtney, R: 1 article (01/2011)
9. Fiedler, W: 1 article (01/2011)
10. Giaccone, G: 1 article (01/2011)

Related Diseases

1. Neoplasms (Cancer)

Related Drugs and Biologics

1. Tyrosine Kinase Inhibitors
2. Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
3. Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)
4. Ligands